- Home
- JEM vs BYSI Comparison
JEM vs BYSI Comparison
Compare JEM & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEM
- BYSI
- Stock Information
- Founded
- JEM 2021
- BYSI 2010
- Country
- JEM Hong Kong
- BYSI United States
- Employees
- JEM N/A
- BYSI N/A
- Industry
- JEM
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- JEM
- BYSI Health Care
- Exchange
- JEM NYSE
- BYSI Nasdaq
- Market Cap
- JEM 81.7M
- BYSI 71.0M
- IPO Year
- JEM 2025
- BYSI 2017
- Fundamental
- Price
- JEM $3.72
- BYSI $2.02
- Analyst Decision
- JEM
- BYSI
- Analyst Count
- JEM 0
- BYSI 0
- Target Price
- JEM N/A
- BYSI N/A
- AVG Volume (30 Days)
- JEM 137.1K
- BYSI 25.2K
- Earning Date
- JEM 01-01-0001
- BYSI 08-11-2025
- Dividend Yield
- JEM N/A
- BYSI N/A
- EPS Growth
- JEM 13.72
- BYSI N/A
- EPS
- JEM 0.05
- BYSI N/A
- Revenue
- JEM $11,285,111.00
- BYSI N/A
- Revenue This Year
- JEM N/A
- BYSI N/A
- Revenue Next Year
- JEM N/A
- BYSI N/A
- P/E Ratio
- JEM $88.34
- BYSI N/A
- Revenue Growth
- JEM 4.38
- BYSI N/A
- 52 Week Low
- JEM $3.05
- BYSI $0.98
- 52 Week High
- JEM $7.90
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- JEM N/A
- BYSI 44.82
- Support Level
- JEM N/A
- BYSI $1.87
- Resistance Level
- JEM N/A
- BYSI $2.13
- Average True Range (ATR)
- JEM 0.00
- BYSI 0.15
- MACD
- JEM 0.00
- BYSI -0.01
- Stochastic Oscillator
- JEM 0.00
- BYSI 43.97
About JEM 707 CAYMAN HOLDINGS LIMITED
707 Cayman Holdings Ltd is a Hong Kong-based group that sells quality apparel products and provides supply chain management total solutions to its customers spanning from Western Europe, North America to the Middle East. Its comprehensive range of supply chain management total solutions includes market trend analysis, design and product development, sourcing, production management, quality control and logistics services, and its solutions encompass the total supply chain from conceptualizing the product, the selection of materials until the final delivery of finished apparel products to its customers at their nominated destinations, whether it be a designated port for shipment, its customer's warehouse or the end consumers.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.